Combined neuroprotection in the treatment of post-stroke aphasia

Safronova M.N.; Kovalenko A.V.; Mizurkina O.A.

doi:https://doi.org/10.17116/jnevro201911907120

Close metadata

Abstract:

Objective. To evaluate the efficacy of combined neuroprotection in the restoration of speech function in patients with acute ischemic stroke in the carotid region. Material and methods. The study included 257 patients (median age 60 (55; 72) years) with ischemic stroke and motor or sensorimotor aphasia. The degree of speech recovery was characterized by an increase in the score on the scale of the speech questionnaire (SQ) on the 21st day from the beginning of the disease. Patients were divided into low recovery (ΔSQ ≤6) and high recovery (ΔSQ >6) groups. All patients received neuroprotectors of different groups. Results. The greatest efficacy was shown for cortexin in combination with mexidol: the ΔSQ >6 group included 24 (70.6%) and the group ΔSQ ≤6 10 (29.4%) patients out of 34 patients. The lowest efficacy was observed for gliatilin in monotherapy: an increase was ≤6 points in 24 (68.6%) patients and >6 points in 11 (31.4%), and for combinations of ceraxon and mexidol: 26 (61.9%) and 6 (38.1%) patients with low- and high level of speech recovery, respectively (p=0.041). Conclusion. Combined neuroprotective therapy using drugs with neuromodulatory and antioxidant effects (cortexin and mexidol) in the acute period of ischemic stroke is effective in the treatment of post-stroke aphasia.

Keywords:

aphasia

stroke

combined neuroprotection

cortexin

mexidol

Authors:

Safronova M.N.

Kemerovo State Medical Academy;
Regional Clinical Hospital for War Veterans

Kovalenko A.V.

Hematology Research Center, Ministry of Health of the Russian Federation, Moscow

Mizurkina O.A.

Kemerovo Cardiological Clinic

Close metadata

References:

Shamalov NA, Shetova IM. Kombinirovannaya tsitoprotektsiya v lechenii narushenii mozgovogo krovoobrashcheniya. Effektivnaya Farmakoterapiya. 2011;3:12-14. (In Russ.)
Insul’t. Rukovodstvo dlya vrachei. Pod red. Stakhovskoi L.V., Kotova S.V. M.: MIA; 2014. (In Russ.)
Gusev EI, Skvortsova VI, Kilikovskii VV, Stakhovskaya LV, Airiyan NYu. Problema insul’ta v Rossiiskoi Federatsii. Kachestvo Zhizni. 2006;2(13):10-14. (In Russ.)
Astaeva AV, Epaneshnikova NV. On the characteristics of neuropsychological speech disorders in severe violations of cerebral circulation and the problem of classifying in domestic and foreign neuropsychology. Vestnik Yuzhno-Ural’skogo Gosudarstvennogo Universiteta. Seriya: Psikhologiya. 2012;6(265):73-79. (In Russ.)
Berdnickovitch ES. Restoration of speech disorders — post stroke aphasia. Sotsial’no-gumanitarnye Znaniya. 2014;3:308-314. (In Russ.)
Kadykov AS, Shakhparonova NV. Rannyaya reabilitatsiya bol’nykh, perenesshikh insul’t. Rol’ medikamentoznoi terapii. Nervnye Bolezni. 2014;1:22-25. (In Russ.)
Kuzmina MS, Chelysheva IA, Gerasimova YuA, Lavrentieva LV. Speech disorders in acute cerebral blood circulation disturbances. Vestnik Ivanovskoi Meditsinskoi Akademii. 2013;4:66. (In Russ.)
Luriya AR. Vysshie korkovye funktsii cheloveka i ikh narusheniya pri lokal’nykh porazheniyakh mozga. M.: Akadem. prospekt; 2000. (In Russ.)
Stolyarova LG, Shokhor-Trotskaya MK. Osobennosti dinamiki rechi u bol’nykh s razlichnymi variantami motornoi afazii pri insul’te. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 1981;1:10-15. (In Russ.)
Hillis AE, Tippett DC. Stroke recovery: surprising influences and residual consequences. Advances in Medicine. 2014;1-10. https://doi.org/10.1155/2014/378263
Smania N, Gandolfi M, Aglioti SM, Girardi P, Fiaschi A, Girardi F. How long is the recovery of global aphasia? Twenty-five years of follow-up in a patient with left hemisphere stroke. Neurorehabilitation and Neural Repair. 2010;24(9):871-875. https://doi.org/10.1177/1545968310368962
Vishneva AE. Features of self-esteem in patients with various speech disorders. Natsional’nyi Psikhologicheskii Zhurnal. 2016;1(21):53-61. (In Russ.) https://doi.org/10.11621/npj.2016.0107
Tsvetkova LS. Neiropsikhologiya i afaziya: novyi podkhod. Voronezh: Izdatel’stvo Moskovskogo psikhologo-sotsial’nogo instituta; MODEK; 2001. (In Russ.)
Shipkova KM. Quality of Life, Needs and Expectations in Aphasics. Aktual’nye problemy Psikhologicheskogo Znaniya. 2015;2:114-124. (In Russ.)
Fotiadou D, Northcott S, Chatzidaki A, Hilari K. Aphasia blog talk: How does stroke and aphasia affect a person’s social relationships? Aphasiology. 2014;28(11):1281-1300. https://doi.org/10.1080/02687038.2014.928664
Hersh D. «Hopeless, sorry, hopeless». Co-constructing narratives of care with people who have aphasia post-stroke. Topics in Language Disorders. 2015;35(3):219-236. https://doi.org/10.1097/tld.0000000000000060
Burlakova MK. Rech’ i afaziya. M.: Meditsina; 1997. (In Russ.)
Tsvetkova LS. Afaziologiya: sovremennye problemy i puti ikh resheniya. Izbrannye psikhologicheskie trudy. M.: MPSI; Voronezh: MODEK; 2011. (In Russ.)
Shakhparonova NV, Kadykov AS, Kashina EM. Post-stroke rehabilitation. Restoration of motor function, speech, cognition. Trudnyi Patsient. 2012;10(11):22-27. (In Russ.)
Voronina TA, Seredenin SB. Nootropnye preparaty, dostizheniya i novye problemy. Eksperimental’naya i Klinicheskaya Farmakologiya. 1998;61(4):3-9. (In Russ.)
Kozhinova AV, Levin OS. Pharmacotherapy patients after ischemic stroke during rehabilitation. Sovremennaya Terapiya v Psikhiatrii i Nevrologii. 2015;1:4-11. (In Russ.)
Lesiovskaya EE. Antihypoxants of direct action — a promising neuroprotectors. Terra Medica. 2012;4:49-57. (In Russ.)
Neiroprotektsiya: modeli, mekhanizmy, terapiya. Pod red. Bera M. Per. s angl. Pod red. Zykova V.P., Kamchatnova P.R. M.: BINOM. Laboratoriya znanii; 2015. (In Russ.)
Majid A. Neuroprotection in stroke: past, present, and future. ISRN Neurology. 2014;1-17. https://doi.org/10.1155/2014/515716
Namura S, Ooboshi H, Liu J, Yenari MA. Neuroprotection after cerebral ischemia. Annals of the New York Academy of Sciences. 2013;1278:25-32. https://doi.org/10.1111/nyas.12087
Rumyantseva SA, Stupin VA, Afanas’ev VV, Barantsevich ER, Bolevich SB, Fedin AI, Silina EV, Khokonov MA. Vtoroi shans (sovremennye predstavleniya ob energokorrektsii). Izd. 2-e ispr. i dop. M.: MIG «Meditsinskaya kniga»; 2011. (In Russ.)
Piradov MA, Tanashyan MM, Domashenko MA, Sergeev DV, Maksimova MYu. Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 1. Acute stroke. Annaly Klinicheskoi i Eksperimental’noi Nevrologii. 2015;9 (1):41-50. (In Russ.)
Carrillo-Mora P, Alcantar-Shramm JM, Almaguer-Benavides KM, Macías-Gallardo, Fuentes-Bello A, Rodríguez-Barragán MA. Pharmacological Stimulation of Neuronal Plasticity in Acquired Brain Injury. Clinical Neuropharmacology. 2017;40(3):131-139. https://doi.org/10.1097/wnf.0000000000000217
Lincoln NB. The Speech Questionnaire: an assessment of functional language ability. International Rehabilitation Medicine. 1982;4(3):114-117.
Dmitrienko DV, Shetekauri SA. Tserebroprotektsiya neiropeptidami ostreishego perioda ishemicheskogo insul’ta. Neiroprotektsiya ostroi i khronicheskii nedostatochnosti mozgovogo krovoobrashcheniya. Pod red. Skoromtsa A.A., D’yakonova M.M. SPb.: Nauka; 2007. (In Russ.)
Kovalenko AV, Safronova MN, Mizyurkina OA. Vliyanie korteksina na vosstanovlenie rechevoi funktsii v ostrom periode insul’ta. Tserebrovaskulyarnaya patologiya — novye vozmozhnosti nizkodozirovannoi neiroprotektsii. Pod red. Skoromtsa A.A., Stakhovskoi L.V. SPb.: Nauka; 2014. (In Russ.)
Kurenkova NA, Philatova MS, Popov DV, Makarova LD, Mahankov OV. Efficacy of cortexin in case of early rehabilitation of patients with ischemic stroke. Obozrenie Psikhiatrii i Meditsinskoi Psikhologii im. V.M. Bekhtereva. 2015;3:115-117. (In Russ.)
Mikhalevich SA, Zhivitskaya NYu. Tserebral’nye insul’ty — rasstroistva rechi, dinamika pri lechenii korteksinom. Neiroprotektsiya ostroi i khronicheskii nedostatochnosti mozgovogo krovoobrashcheniya. Pod red. Skoromtsa A.A., D’yakonova M.M. SPb.: Nauka; 2007. (In Russ.)
Skorokhodov AP. Opyt neiroprotektsii pri terapii ishemicheskogo i gemorragicheskogo insul’tov. Neiroprotektsiya ostroi i khronicheskii nedostatochnosti mozgovogo krovoobrashcheniya. Pod red. Skoromtsa A.A., D’yakonova M.M. SPb.: Nauka; 2007. (In Russ.)
Maksimova MYu, Kistenev BA, Domashenko MA, Fedorova TN, Sharypova TN. Klinicheskaya effektivnost’ i antioksidantnaya aktivnost’ mildronata pri ishemicheskom insul’te. Rossiiskii Kardiologicheskii Zhurnal. 2009;4(78):55-63. (In Russ.)
Maksimova MYu, Fedorova TN, Sharypova TN. Primenenie mildronata v lechenii bol’nykh s narusheniyami mozgovogo krovoobrashcheniya. Farmateka. 2013;9(262):84-94. (In Russ.)
Shishkova VN, Zotova LI, Remennik AYu, Kerimova EI. Effects of Cerebrolysin on Post-Stroke Aphasia and Nerve Growth Factor Levels in Patients with Impaired Carbohydrate Metabolism. Doktor.Ru. 2015;5-6(106-107):25-30. (In Russ.)
Shishkova VN, Zotova LI, Maljukova NG, Sutjusheva IR, Kan NV, Gasanova EM, Kerimova EI. An assessment of cerebrolysin effect on BDNF level in patients with post stroke aphasia depending on carbohydrate metabolism disorders. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(5):57-63. (In Russ.) https://doi.org/10.17116/jnevro20151155157-63
Belskaya GN, Pizova NV, Sokolov MA, Izmalov IA. Neuroprotection influence on course of cerebral stroke. Meditsinskii Sovet. 2016;11:26-31. (In Russ.) https://doi.org/10.21518/2079-701x-2016-11-26-31
Belskaya GN, Krilova LG, Sokolov MA, Izmailov IA. Possibilities of the treatment of speech impairment in the acute stage of ischemic stroke using neuroprotective therapy. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(9-2):60-63. (In Russ.) https://doi.org/10.17116/jnevro20151159260-63
Kovalenko AV, Safronova MN. The effect of cellex on cognitive and speech impairments in the acute stage of stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(1):40-44. (In Russ.) https://doi.org/10.17116/jnevro20151151140-44
Kotov SV, Belova YuA, Scherbakova MM, Chervinskaya AD, Isakova EV, Volchenkova TV. Restoring of the speech functions in patients with aphasia in the early rehabilitation period of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(2):38-41. (In Russ.) https://doi.org/10.17116/jnevro20171172138-41
Fedin AI, Rumyantseva SA, Piradov MA, Sholomov II. Effektivnost’ neirometabolicheskogo protektora tsitoflavina pri infarkte mozga (mnogotsentrovoe randomizirovannoe issledovanie). Prakticheskaya Meditsina. 2007;3(22):78. (In Russ.)
Odinak MM, Voznyuk IA, Piradov MA, Rumyantseva SA, Kuznetsov AN, Yanishevskii SN, Golokhvastov SYu, Tsygan NV. Mnogotsentrovoe (pilotnoe) issledovanie effektivnosti gliatilina pri ostrom ishemicheskom insul’te. Annaly Klinicheskoi i Eksperimental’noi Nevrologii. 2010;4(1):20-28. (In Russ.)
Pomerantsev IA, Shutenko IV. Opyt primeneniya gliatilina pri rechevoi reabilitatsii bol’nykh s motornoi afaziei posle perenesennogo ishemicheskogo insul’ta. Nervnye Bolezni. 2004;2:28-29. (In Russ.)
Greener J, Enderby P, Whurr R. Pharmacological treatment for aphasia following stroke. Cochrane Database of Systematic Reviews. 2001;4:CD000424. Accessed April 4, 2018. http://cochranelibrary-wiley.com/wol1/doi/10.1002/14651858.CD000424/full https://doi.org/10.1002/14651858.cd000424
Khodzhaeva NA. Neiroprotektornaya terapiya ishemicheskogo mozgovogo insul’ta putem kombinirovannogo primeneniya preparatov mildronata i tserebrolizina. Nevrologiya (Tashkent). 2007;1:19-21. (In Russ.)